Prothena Corporation plc Stock Analysis & AI Score
Prothena Corporation plc (PRTA) has an ST Score of 63.0 (B), driven by its Forecast (A) and held back by its Growth (C-). Analysts rate it Buy with a $30.00 price target (+260.6% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Prothena Corporation plc (PRTA) has an ST Score of 63.0 (B), driven by its Forecast (A) and held back by its Growth (C-). Analysts rate it Buy with a $30.00 price target (+260.6% upside).
- Strongest
- ForecastA
- Weakest
- GrowthC-
All factor grades
- ForecastA
- ProfitabilityA-
- Financial StrengthA-
- ValuationB+
- MomentumB-
- GrowthC-
- Piotroski3/9
Contact
PRTA stock: frequently asked questions
What is PRTA's ST Score?
Prothena Corporation plc (PRTA) has an ST Score of 63.0 (B), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is PRTA a buy, hold, or sell?
Analysts rate PRTA a Buy, with a price target of $30.00 (+260.6% vs the current price). Our ST Score grades it B (63.0/100). The ST Score is a data-driven signal, not a recommendation.
What are PRTA's factor grades?
Valuation B+, Profitability A-, Financial Strength A-, Momentum B-, Growth C-, Forecast A.
What is PRTA's valuation grade?
Prothena Corporation plc (PRTA) earns a valuation grade of B+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is PRTA's growth grade?
Prothena Corporation plc (PRTA) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is PRTA's profitability grade?
Prothena Corporation plc (PRTA) earns a profitability grade of A-, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is PRTA's financial strength grade?
Prothena Corporation plc (PRTA) earns a financial strength grade of A-, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for PRTA?
The average analyst price target for Prothena Corporation plc (PRTA) is $30.00 from 28 analysts, which is +260.6% versus the recent price of $8.32.
What is PRTA's Piotroski score?
Prothena Corporation plc (PRTA) has a Piotroski F-Score of 3 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.